Viewing Study NCT06789757


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2026-01-25 @ 5:51 AM
Study NCT ID: NCT06789757
Status: RECRUITING
Last Update Posted: 2025-10-07
First Post: 2024-11-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
Sponsor: Inova Health Care Services
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atezolizumab View
None Bevacizumab View
None Memantine View